Post COVID-19 cholangiopathy - A deep dive.
作者信息
Bethineedi Lakshmi Deepak, Suvvari Tarun Kumar
机构信息
Andhra Medical College, Visakhapatnam, Andhra Pradesh, India.
Dr. NTR University of Health Sciences, Andhra Pradesh, India.
出版信息
Dig Liver Dis. 2021 Oct;53(10):1235-1236. doi: 10.1016/j.dld.2021.08.001. Epub 2021 Aug 9.
Abstract
摘要
相似文献
1
Post COVID-19 cholangiopathy - A deep dive.新冠后胆管病——深入探究
Dig Liver Dis. 2021 Oct;53(10):1235-1236. doi: 10.1016/j.dld.2021.08.001. Epub 2021 Aug 9.
2
Post-COVID-19 Cholangiopathy: A Novel Entity.新冠病毒感染相关胆管病：一种新的疾病实体。
Am J Gastroenterol. 2021 May 1;116(5):1077-1082. doi: 10.14309/ajg.0000000000001154.
3
Reply to: "Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered".回复：“COVID-19患者的进行性胆管病：除氯胺酮诱导的胆管病外，应考虑其他可能的诊断”。
J Hepatol. 2021 Oct;75(4):990-992. doi: 10.1016/j.jhep.2021.06.024. Epub 2021 Jun 24.
4
Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case Report.新冠病毒感染后胆管病——肝移植的新适应证：病例报告。
Transplant Proc. 2021 May;53(4):1132-1137. doi: 10.1016/j.transproceed.2021.03.007. Epub 2021 Mar 12.
5
Primary biliary cholangitis associated with SARS-CoV-2 infection.与新型冠状病毒2型感染相关的原发性胆汁性胆管炎
J Hepatol. 2021 May;74(5):1245-1246. doi: 10.1016/j.jhep.2021.02.006. Epub 2021 Feb 19.
6
Care of the postcoronavirus disease 2019 patient.2019冠状病毒病康复患者的护理
Curr Opin Pulm Med. 2021 May 1;27(3):199-204. doi: 10.1097/MCP.0000000000000767.
7
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
8
We report a patient who presented intrahepatic cholangitis and cholecystitis after SARS-CoV-2 infection.我们报告了一名在感染新型冠状病毒2后出现肝内胆管炎和胆囊炎的患者。
J Gastroenterol Hepatol. 2021 Aug;36(8):2037. doi: 10.1111/jgh.15537. Epub 2021 Jun 9.
9
Impact of liver injury on the severity of COVID-19: a systematic review with meta-analysis.肝损伤对 COVID-19 严重程度的影响：系统评价与荟萃分析。
Rev Esp Enferm Dig. 2021 Feb;113(2):125-135. doi: 10.17235/reed.2020.7397/2020.
10
COVID-19-associated pancreatic dysfunction.新型冠状病毒肺炎相关胰腺功能障碍
Hong Kong Med J. 2021 Apr;27(2):157-159. doi: 10.12809/hkmj209056. Epub 2021 Apr 9.
引用本文的文献
1
Altered liver hemodynamics in patients with COVID-19: a cross sectional study.2019冠状病毒病患者肝脏血流动力学改变：一项横断面研究
J Ultrasound. 2025 Apr 2. doi: 10.1007/s40477-025-01012-z.
2
Post-COVID-19 cholangiopathy: Systematic review.新冠病毒感染后胆管病：系统评价
World J Methodol. 2023 Sep 20;13(4):296-322. doi: 10.5662/wjm.v13.i4.296.
3
Post-COVID-19 syndrome mimicking cholangiocarcinoma: A case report.酷似胆管癌的新冠后综合征：一例报告
Clin Case Rep. 2023 May 30;11(6):e7449. doi: 10.1002/ccr3.7449. eCollection 2023 Jun.
4
COVID-Associated Cast-Forming Cholangiopathy: A Commentary on Disease Mechanism, Treatment, and Prognosis.新型冠状病毒肺炎相关的铸型形成性胆管病：疾病机制、治疗及预后述评
Hepat Med. 2023 Mar 28;15:27-32. doi: 10.2147/HMER.S384176. eCollection 2023.
5
Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis - A review of cholangiographic and ultrasound imaging.继发性硬化性胆管炎和IgG4相关性硬化性胆管炎——胆管造影和超声成像综述
Endosc Ultrasound. 2023 Mar-Apr;12(2):181-199. doi: 10.4103/EUS-D-22-00208.
6
Post-COVID cholangiopathy: A narrative review.新冠后胆管病：一篇叙述性综述。
Gastroenterol Hepatol. 2023 Jun-Jul;46(6):474-482. doi: 10.1016/j.gastrohep.2022.09.004. Epub 2022 Sep 27.
Zotero 插件